Live Stream

Transcatheter Interventions Online | Day 3 – Recent trials & future technologies


The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally, interspersed with presentations and debate sessions.

CME Accreditation

This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/

Day 1 - Structural Heart Interventions

10th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 2: Complex & High Risk Indicated PCI

11th June 4-8pm CEST (10am – 2pm ET)

Watch on demand

Day 3: Updates on recent trials & future technologies

12th June 4-8pm CEST (10am – 2pm ET)

Watch on demand


Nicolas M Van Mieghem

Nicolas M Van Mieghem

Kendra J Grubb

Kendra J Grubb

David Hildick-Smith

David Hildick-Smith

Holger Thiele

Holger Thiele

This live stream is supported by:


4 - 5.30pm: PART 3.1 - Trials - 90 minutes

Intro: Nicolas Van Mieghem
SESSION CHAIRS: Roxana Mehran, Holger Thiele
SESSION PANEL: Ajay Kirtane, Lars Sondergaard, Kendra Grubb, David Hildick-Smith

1. ISCHEMIA practical perspectives – 15 minutes – Ajay Kirtane
15 minutes discussion

2. Latest in pharmacology: acute and stable coronary syndromes – 15 minutes – Roxana Mehran
15 minutes discussion

3. Recent TAVI data – 15 minutes – Lars Sondergaard
15 minutes discussion

5.30 - 6.30pm: PART 3.2 - Live Cases - 60 minutes

1. Erasmus Medical Center, NL (Lean TAVI)

2. Erasmus Medical Center, NL (Physiology Guided MVD PCI)

6.30 - 7.50pm: PART 3.3 - Future Technologies and Controversies - 80 minutes

SESSION CHAIRS: Nicolas Van Mieghem, Ajay Kirtane
SESSION PANEL: Holger Thiele, Didier Tchetche, David Hildick-Smith, Roxana Mehran
1. MCS in HRPCI – Changing perspectives? – 15 minutes – Holger Thiele
15 minutes discussion

2. Embolic protection in TAVI – 15 minutes – David Hildick-Smith
10 minutes discussion

3. Non-hyperemic angio-, OCT-, MSCT derived coronary physiology – 15 minutes – Joost Daemen
10 minutes discussion

7.50pm: Wrap up of Day 3

Led by Nicolas Van Mieghem - 10 minutes

Learning Objectives

Following the activities, the participants will be able to:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

Target Audience

  • Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Personal History

From an early age, Professor Nicolas Maria Van Mieghem decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them. I wanted to enter a profession that would channel my energy— I was always a busy child,” he says. 

A budding athlete, he was a member of Belgium’s national swimming team but soon realized that medicine was his true calling. His father was a general cardiologist and one of his biggest influences early in his career.

Professor Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. 

His mantra is mens sana in corpore sano (a healthy mind in a healthy body). He remains an avid swimmer and cyclist and follows a number of professional sports. “Like all Belgians, I love to watch the big cycling events—the classic cycle races, the Tour de France, the Giro d’Italia, the Vuelta a España,” he says. 

Van Mieghem believes that a great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 


Academic History


In 2007, Professor Van Mieghem obtained his medical and cardiology degrees at the Catholic University of Leuven, Belgium. He completed fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands.2 His PhD focused on transcatheter valve therapies.3

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Professor Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

Professor Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV and Abiomed.7


Career Overview

After his fellowships, Professor Van Mieghem joined the department of interventional cardiology at the Thorax Centre, Erasmus Medical Center, as a senior staff member in February 2010. He is now working there as a Full Professor of Interventional Cardiology.2

As well as his involvement in the percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals.4 Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies.3 He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.3


Career Timeline

  • 2008 - 2009: Fellow, Interventional Cardiology, Lenox Hill Hospital
  • 2010: Joined the senior staff, Interventional Cardiology, Thorax Centre, Erasmus MC
  • 2014: Clinical Director, Interventional Cardiology, Erasmus MC
  • 2019 - Present: Full Professor, Interventional Cardiology, Erasmus MC
  • Present: Medical Director, Interventional Cardiology, Thorax Centre 


Areas of Speciality4

  • Interventional Cardiology
  • Transcatheter Heart Valve Interventions



  1. https://cardiovascularnews.com/nicolas-van-mieghem/
  2. https://esc365.escardio.org/Person/418700-dr-van-mieghem-nicolas 
  3. https://www.radcliffecardiology.com/authors/nicolas-m-van-mieghem 
  4. https://www.ecri-trials.com/faculty/nicolas-van-mieghem/ 
  5. https://www.cardialysis.com/core-lab/supervising-cardiologists/ 
  6. https://www.worldcat.org/title/transcatheter-aortic-valve-therapies-from-cutting-edge-to-mainstream-catheter-gebonden-aortaklep-implantatie/oclc/892053833 
  7. https://www.jacc.org/doi/pdf/10.1016/j.jcin.2020.12.021 


 Prof Van Mieghem is on the ICR3 Editorial Board.


View full profile

Kendra J Grubb

Kendra J Grubb

Personal History

Dr Kendra Grubb is the surgical director of the structural heart and valve center at Emory Healthcare. She is also an associate professor of surgery at Emory University School of Medicine.

Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centered approach to the treatment of cardiovascular disease.


Academic History

After obtaining her BS in Biology from the University of Southern California (1999), Kendra attended the University of Southern California, where she received her a master’s in health administration from the Sol Price School of Public Policy (2001), followed by an MD degree at the Keck School of Medicine (2005).

She pursued a general surgery residency at the University of Illinois at Chicago between 2005 and 2010, a fellowship in cardiothoracic surgery at the University of Virginia in Charlottesville between 2010 and 2012, then a fellowship in interventional cardiology and transcatheter therapies at New York-Presbyterian/Columbia University Medical Center from 2012 to 2013.

Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.


Career Overview

Kendra is currently the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory, she was the director of minimally invasive cardiac surgery and the surgical director of the heart valve program at the University of Louisville.

Kendra’s research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of aneurysms of the descending thoracic aorta.


Career Timeline

  • 2018 - Present: Surgical Director, Structural Heart and Valve Center, Emory Healthcare
  • 2018 - Present: Associate Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine
  • Previous: University of Louisville
    • Director, Minimally Invasive Cardiac Surgery 
    • Assistant Professor, Cardiac Surgery


Areas of Speciality

  • Adult Cardiovascular Surgery
  • Hybrid Revascularization
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Valvular heart disease



  • 2016: Louisville Business First, Forty Under 40
  • 2016: Teacher of the Year, Department of Cardiovascular and Thoracic Surgery, University of Louisville
  • 2015: Healthcare Innovations Award, Kentucky Life Sciences Council, MediStar Awards
  • 2015: Olga Jonasson Honored Alumnus, University of Illinois
  • 2014: Leadership Academy, American Association for Thoracic Surgery
  • 2011: Case Presentation Finalist, Mechanical Circulatory Support in Advanced Heart Failure, Thoratec
  • 2010: Thoracic Surgery Directors Association, TSDA Boot Camp Certificate of Achievement
  • 2010: Surgery Resident Teacher Award, Department of Surgery, University of Illinois at Chicago


View full profile

David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.

A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment. 

View full profile

Holger Thiele

Holger Thiele

Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Internal Medicine/Cardiology of the Heart Center Leipzig which is affiliated with the University of Leipzig. 

View full profile